Instituto Hermes Pardini SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Instituto Hermes Pardini SA with three other pharmaceutical manufacturers in Latin America: Laboratorios Richmond SACIF of ARGENTINA (2019 sales of 3.90 billion Argentinian Pesos [US$53.52 million] of which 66% was Private Market), Fleury SA (2.91 billion Brazilian Reals [US$535.21 million] of which 84% was Diagnostic Medicine), and Ouro Fino Saude Animal Participacoes SA (619.59 million Brazilian Reals [US$114.15 million] of which 75% was Production Animals).

Sales Analysis. During the year ended December of 2019, sales at Instituto Hermes Pardini SA were 1.35 billion Brazilian Reals (US$249.38 million). This is an increase of 12.4% versus 2018, when the company's sales were 1.20 billion Brazilian Reals. This was the fifth consecutive year of sales increases at Instituto Hermes Pardini SA (and since 2014, sales have increased a total of 94%).